10 results on '"Jourdain, Marine"'
Number of results to display per page
Search Results
2. Identifying the target population for primary Respiratory Syncytial Virus two-step 2 prevention in infants: Normative Outcome of Hospitalisation Assessment for Newborns (NOHAN)
- Author
-
Jourdain, Marine, Benchaib, Mehdi, Ploin, Dominique, Gillet, Yves, Javouhey, Etienne, Horvat, C��me, Massoud, Mona, Butin, Marine, Claris, Olivier, Lina, Bruno, Lyon, The VRS Study Group In, and Jean-Sebastien Casalegno
- Published
- 2022
- Full Text
- View/download PDF
3. Real-time, portable genome sequencing for Ebola surveillance
- Author
-
Quick, Joshua, Loman, Nicholas J., Duraffour, Sophie, Simpson, Jared T., Severi, Ettore, Cowley, Lauren, Bore, Joseph Akoi, Koundouno, Raymond, Dudas, Gytis, Mikhail, Amy, Ouédraogo, Nobila, Afrough, Babak, Bah, Amadou, Baum, Jonathan H. J., Becker-Ziaja, Beate, Boettcher, Jan Peter, Cabeza-Cabrerizo, Mar, Camino-Sánchez, Álvaro, Carter, Lisa L., Doerrbecker, Juliane, Enkirch, Theresa, Dorival, Isabel García-, Hetzelt, Nicole, Hinzmann, Julia, Holm, Tobias, Kafetzopoulou, Liana Eleni, Koropogui, Michel, Kosgey, Abigael, Kuisma, Eeva, Logue, Christopher H., Mazzarelli, Antonio, Meisel, Sarah, Mertens, Marc, Michel, Janine, Ngabo, Didier, Nitzsche, Katja, Pallasch, Elisa, Patrono, Livia Victoria, Portmann, Jasmine, Repits, Johanna Gabriella, Rickett, Natasha Y., Sachse, Andreas, Singethan, Katrin, Vitoriano, Inês, Yemanaberhan, Rahel L., Zekeng, Elsa G., Racine, Trina, Bello, Alexander, Sall, Amadou Alpha, Faye, Ousmane, Faye, Oumar, Magassouba, NʼFaly, Williams, Cecelia V., Amburgey, Victoria, Winona, Linda, Davis, Emily, Gerlach, Jon, Washington, Frank, Monteil, Vanessa, Jourdain, Marine, Bererd, Marion, Camara, Alimou, Somlare, Hermann, Camara, Abdoulaye, Gerard, Marianne, Bado, Guillaume, Baillet, Bernard, Delaune, Déborah, Nebie, Koumpingnin Yacouba, Diarra, Abdoulaye, Savane, Yacouba, Pallawo, Raymond Bernard, Gutierrez, Giovanna Jaramillo, Milhano, Natacha, Roger, Isabelle, Williams, Christopher J., Yattara, Facinet, Lewandowski, Kuiama, Taylor, James, Rachwal, Phillip, Turner, Daniel J., Pollakis, Georgios, Hiscox, Julian A., Matthews, David A., Shea, Matthew K. Oʼ, Johnston, Andrew McD., Wilson, Duncan, Hutley, Emma, Smit, Erasmus, Di Caro, Antonino, Wölfel, Roman, Stoecker, Kilian, Fleischmann, Erna, Gabriel, Martin, Weller, Simon A., Koivogui, Lamine, Diallo, Boubacar, Keïta, Sakoba, Rambaut, Andrew, Formenty, Pierre, Günther, Stephan, and Carroll, Miles W.
- Published
- 2016
- Full Text
- View/download PDF
4. Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter?
- Author
-
van Summeren, Jojanneke, Meijer, Adam, Aspelund, Guðrún, Casalegno, Jean Sebastien, Erna, Guðrún, Hoang, Uy, Lina, Bruno, de Lusignan, Simon, Teirlinck, Anne C., Thors, Valtýr, Paget, John, Ouziel, Antoine, Tardy, Jean-claude, Gaucherand, Pascal, Massardier, Jerome, Polazzi, Stephanie, Duclos, Antoine, Benchaib, Mehdi, Cartier, Regine, Jourdain, Marine, Ottmann, Michelle, Kramer, Rolf, Fiorini, Sylvie, Rivat, Nathalie, Mekki, Yahia, Fort-Jacquier, Julie, Barral, Maud-Catherine, Noelie, Vey, Haesebaert, Julie, Horvat, Come, Vidoni, Leo, Reynes, Jean-Marc, Eleouet, Jean-Francois, Josset, Laurence, Receveur, Matthieu, Javouhey, Etienne, Ploin, Dominique, Valette, Martine, Fanget, Remi, Targe, Sandrine Couray, Myar-Dury, Anne-Florence, Doret-Dion, Muriel, Massoud, Mona, Masson, Elsa, Bard, Emilie, Queromes, Gregory, Vanhems, Phillipe, Claris, Olivier, Butin, Marine, Ader, Florence, Bin, Sylvie, Gaymard, Alexandre, Morfin, Florence, Gillet, Yves, Netherlands Institute for Health Services Research [Utrecht] (NIVEL), National Institute for Public Health and the Environment [Bilthoven] (RIVM), Directorate of Health [Reykjavík], Institut des Agents Infectieux [Lyon] (IAI), Hospices Civils de Lyon (HCL), Landspitali National University Hospital of Iceland, University of Oxford [Oxford], Children’s Hospital [Reykjavik, Iceland], University of Iceland [Reykjavik], This study is performed as a side project of the RSV ComNet study. The aim of the RSV ComNet project is to measure the disease burden of RSV in children aged ≤5 years in primary care, and is funded by Sanofi Pasteur and AstraZeneca., VRS study group in Lyon: Antoine Ouziel, Jean-claude Tardy, Pascal Gaucherand, Jerome Massardier, Stephanie Polazzi, Antoine Duclos, Mehdi Benchaib, Regine Cartier, Marine Jourdain, Michelle Ottmann, Rolf Kramer, Sylvie Fiorini, Nathalie Rivat, Yahia Mekki, Julie Fort-Jacquier, Maud-Catherine Barral, Vey Noelie, Julie Haesebaert, Come Horvat, Leo Vidoni, Jean-Marc Reynes, Jean-Francois Eleouet, Laurence Josset, Matthieu Receveur, Etienne Javouhey, Dominique Ploin, Martine Valette, Remi Fanget, Sandrine Couray Targe, Anne-Florence Myar-Dury, Muriel Doret-Dion, Mona Massoud, Elsa Masson, Emilie Bard, Gregory Queromes, Phillipe Vanhems, Olivier Claris, Marine Butin, Florence Ader, Sylvie Bin, Alexandre Gaymard, Florence Morfin, Yves Gillet, and Lyon, VRS study group in
- Subjects
Author's Correction ,0301 basic medicine ,Veterinary medicine ,viruses ,Iceland ,surveillance data ,MESH: Respiratory Syncytial Virus, Human ,Respiratory syncytial virus ,0302 clinical medicine ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,MESH: Child ,Epidemiology ,MESH: COVID-19 ,030212 general & internal medicine ,Respiratory system ,Child ,virus diseases ,RSV ,respiratory system ,MESH: Iceland ,MESH: Infant ,Europe ,[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology ,epidemiology ,France ,Seasons ,Winter season ,Rapid Communication ,medicine.medical_specialty ,2019-20 coronavirus outbreak ,Surveillance data ,Coronavirus disease 2019 (COVID-19) ,COVID-19 pandemic ,Respiratory Syncytial Virus Infections ,Biology ,Virus ,03 medical and health sciences ,MESH: Respiratory Syncytial Virus Infections ,Virology ,medicine ,Humans ,MESH: SARS-CoV-2 ,MESH: Humans ,SARS-CoV-2 ,Public Health, Environmental and Occupational Health ,Small children ,COVID-19 ,Infant ,MESH: France ,030104 developmental biology ,Respiratory Syncytial Virus, Human ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,MESH: Europe ,MESH: Seasons - Abstract
International audience; Since the introduction of non-pharmacological interventions to control COVID-19, respiratory syncytial virus (RSV) activity in Europe has been limited. Surveillance data for 17 countries showed delayed RSV epidemics in France (≥ 12 w) and Iceland (≥ 4 w) during the 2020/21 season. RSV cases (predominantly small children) in France and Iceland were older compared with previous seasons. We hypothesise that future RSV epidemic(s) could start outside the usual autumn/winter season and be larger than expected. Year-round surveillance of RSV is of critical importance.
- Published
- 2021
- Full Text
- View/download PDF
5. Characteristics of the delayed respiratory syncytial virus epidemic, 2020/2021, Rhône Loire, France
- Author
-
Casalegno, Jean-Sebastien, Ploin, Dominique, Cantais, Aymeric, Masson, Elsa, Bard, Emilie, Valette, Martine, Fanget, Remi, Targe, Sandrine Couray, Myar-Dury, Anne-Florence, Doret-Dion, Muriel, Massoud, Mona, Queromes, Gregory, Vanhems, Philippe, Claris, Olivier, Butin, Marine, Pillet, Sylvie, Ader, Florence, Bin, Sylvie, Gaymard, Alexandre, Lina, Bruno, Morfin, Florence, Javouhey, Etienne, Gillet, Yves, Ouziel, Antoine, Tardy, Jean-claude, Gaucherand, Pascal, Panetta, Luc, Massardier, Jerome, Polazzi, Stephanie, Duclos, Antoine, Benchaib, Mehdi, Cartier, Regine, Jourdain, Marine, Ottmann, Michelle, Kramer, Rolf, Fiorini, Sylvie, Rivat, Nathalie, Mekki, Yahia, Fort-Jacquier, Julie, Barral, Maud-Catherine, Noelie, Vey, Haesebaert, Julie, Horvat, Come, Vidoni, Leo, Reynes, Jean-Marc, Eleouet, Jean-Francois, Josset, Laurence, Receveur, Matthieu, Institut des Agents Infectieux [Lyon] (IAI), Hospices Civils de Lyon (HCL), Centre National de Référence des Virus des Infections Respiratoires (dont la Grippe) [Lyon] (CNR - laboratoire associé), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Virology and human respiratory Pathologies - Virology and human respiratory Pathologies (VirPath), Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hôpital Femme Mère Enfant [CHU - HCL] (HFME), Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E), Groupe Immunité des Muqueuses et Agents Pathogènes (GIMAP), Université Jean Monnet - Saint-Étienne (UJM), Hôpital Edouard Herriot [CHU - HCL], Santé publique, épidémiologie et écologie évolutive des maladies infectieuses (PHE3ID), Pôle Information Médicale Evaluation Recherche (IMER), Hôpital de la Croix-Rousse [CHU - HCL], VRS study group in Lyon: Antoine Ouziel, Jean-claude Tardy, Pascal Gaucherand, Luc Panetta, Jerome Massardier, Stephanie Polazzi, Antoine Duclos, Mehdi Benchaib, Regine Cartier, Marine Jourdain, Michelle Ottmann, Rolf Kramer, Sylvie Fiorini, Nathalie Rivat, Yahia Mekki, Julie Fort-Jacquier, Maud-Catherine Barral, Vey Noelie, Julie Haesebaert, Come Horvat, Leo Vidoni, Jean-Marc Reynes, Jean-Francois Eleouet, Laurence Josset, Matthieu Receveur, Reynes, Jean-Marc, Centre National de Référence des Virus des Infections Respiratoires (dont la Grippe) [Lyon] (CNR), Centre International de Recherche en Infectiologie - UMR (CIRI), École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), and Centre Hospitalier Universitaire de Saint-Etienne (CHU de Saint-Etienne)
- Subjects
0301 basic medicine ,Pediatrics ,Epidemiology ,pharmacological interventions ,MESH: Hospitalization ,MESH: Respiratory Syncytial Virus, Human ,disease burden ,0302 clinical medicine ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,MESH: Child ,030212 general & internal medicine ,Respiratory system ,Child ,Respiratory Tract Infections ,[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology ,Respiratory tract infections ,Incidence (epidemiology) ,RSV ,MESH: Infant ,Hospitalization ,non-pharmacological interventions ,[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology ,[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,bronchiolitis ,France ,Rapid Communication ,Adult ,medicine.medical_specialty ,Respiratory Syncytial Virus Infections ,Virus ,MESH: Respiratory Syncytial Virus Infections ,03 medical and health sciences ,Virology ,Lower respiratory tract infection ,medicine ,Humans ,Epidemics ,MESH: Epidemics ,Disease burden ,MESH: Humans ,business.industry ,SARS-CoV-2 ,Public Health, Environmental and Occupational Health ,Outbreak ,COVID-19 ,Infant ,MESH: Adult ,medicine.disease ,MESH: France ,030104 developmental biology ,[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie ,Bronchiolitis ,Respiratory Syncytial Virus, Human ,MESH: Respiratory Tract Infections ,SARI ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,business - Abstract
International audience; The Rhône-Loire metropolitan areas’ 2020/21 respiratory syncytial virus (RSV) epidemic was delayed following the implementation of non-pharmaceutical interventions (NPI), compared with previous seasons. Very severe lower respiratory tract infection incidence among infants ≤ 3 months decreased twofold, the proportion of cases among children aged > 3 months to 5 years increased, and cases among adults > 65 years were markedly reduced. NPI appeared to reduce the RSV burden among at-risk groups, and should be promoted to minimise impact of future RSV outbreaks.
- Published
- 2021
- Full Text
- View/download PDF
6. Identifying the Target Population for Primary Respiratory Syncytial Virus Two-Step Prevention in Infants: Normative Outcome of Hospitalisation Assessment for Newborns (NOHAN).
- Author
-
Jourdain, Marine, Benchaib, Mehdi, Ploin, Dominique, Gillet, Yves, Javouhey, Etienne, Horvat, Come, Massoud, Mona, Butin, Marine, Claris, Olivier, Lina, Bruno, and Casalegno, Jean-Sebastien
- Subjects
RESPIRATORY syncytial virus ,NEWBORN screening ,INFANTS ,MOTHER-infant relationship ,BIRTH weight ,HUMAN metapneumovirus infection - Abstract
Background: Respiratory syncytial virus (RSV) is the leading cause of acute respiratory infection- related hospitalisations in infants (RSVh). Most of these infants are younger than 6 months old with no known risk factors. An efficient RSVh prevention program should address both mothers and infants, relying on Non-Pharmaceutical (NPI) and Pharmaceutical Interventions (PI). This study aimed at identifying the target population for these two interventions. Methods: Laboratory-confirmed RSV-infected infants hospitalised during the first 6 months of life were enrolled from the Hospices Civils de Lyon birth cohort (2014 to 2018). Clinical variables related to pregnancy and birth (sex, month of birth, birth weight, gestational age, parity) were used for descriptive epidemiology, multivariate logistic regression, and predictive score development. Results: Overall, 616 cases of RSVh in 45,648 infants were identified. Being born before the epidemic season, prematurity, and multiparity were independent predictors of RSVh. Infants born in January or June to August with prematurity and multiparity, and those born in September or December with only one other risk factor (prematurity or multiparity) were identified as moderate-risk, identifying the mothers as candidates for a first-level NPI prevention program. Infants born in September or December with prematurity and multiparity, and those born in October or November were identified as high-risk, identifying the mothers and infants as candidates for a second-level (NPI and PI) intervention. Conclusions: It is possible to determine predictors of RSVh at birth, allowing early enrollment of the target population in a two-level RSV prevention intervention. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. BURDEN OF HOSPITALIZATION DUE TO RESPIRATORY SYNCYTIAL VIRUS (RSV)-VERY SEVERE ASSOCIATED LOWER RESPIRATORY TRACT INFECTION (VS-ALRI) IN THE FIRST YEAR OF LIFE IN A MAJOR URBAN CITY, LYON, FRANCE. On behalf the VRS Study group in Lyon
- Author
-
C Horvat, L Duclaux-Loras, A Myard-Dury, B Lina, E Javouhey, Y Gillet, J S Casalegno, Ottmann, Michele, Ploin, Dominique, Gaymard, Alexandre, Kramer, Rolf, Benchaib, Mehdi, Yahia Mekki, Javouhey, Etienne, Duclos, Antoine, Gillet, Yves, Polazzi, Stephanie, Lina, Bruno, Vanhems, Philippe, Claris, Olivier, Valette, Martine, Couray-Targe, Sandrine, Massoud, Mona, Cartier, Régine, Josset, Laurence, Butin, Marine, Bin, Sylvie, Horvat, Côme, Jean-Sebastien Casalegno, Jourdain, Marine, Ouziel, Antoine, Anne-Florence Myard-Dury, Doret-Dion, Muriel, Fiorini, Sylvie, Morfin-Sherpa, Florence, Gaucherand, Pascal, Ader, Florence, Rivat, Nathalie, and Lyon, The VRS Study Group In
- Published
- 2020
- Full Text
- View/download PDF
8. Very severe RSV-associated respiratory tract infection in children living in a French urban city: Incidence and risk factors (ESPID 2020)
- Author
-
L Duclos-Lauras, L Alexandre, A Paul, T Guichard, E Rault, S Fiorini, N Rivat, Ploin, Dominique, Benchaib, Mehdi, Kramer, Rolf, Yahia Mekki, Duclos, Antoine, Javouhey, Etienne, Gillet, Yves, Lina, Bruno, Vanhems, Philippe, Claris, Olivier, Valette, Martine, Couray-Targe, Sandrine, Massoud, Mona, Cartier, Régine, Lyon, The VRS Study Group In, Morfin-Sherpa, Florence, Ottmann, Michele, Bin, Sylvie, Butin, Marine, Horvat, Côme, Jourdain, Marine, Biot, Blandine, Ouziel, Antoine, Doret-Dion, Muriel, Gaucherand, Pascal, Massardier, Jerome, Anne-Florence Myard-Dury, Polazzi, Stephanie, and Jean-Sebastien Casalegno
- Published
- 2020
- Full Text
- View/download PDF
9. Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles.
- Author
-
Tumiotto, Camille, Alves, Bruna M., Recordon-Pinson, Patricia, Jourdain, Marine, Bellecave, Pantxika, Guidicelli, Gwenda-Line, Visentin, Jonathan, Bonnet, Fabrice, Hessamfar, Mojdan, Neau, Didier, Sanchez, Jorge, Brander, Christian, Sajadi, Mohammad, Eyzaguirre, Lindsay, Soares, Esmeralda A., Routy, Jean-Pierre, Soares, Marcelo A., and Fleury, Hervé
- Subjects
ANTIRETROVIRAL agents ,DRUG design ,AIDS vaccines ,HLA histocompatibility antigens ,CD8 antigen ,T cells - Abstract
One of the approaches by which the scientific community is seeking to cure HIV is the use of therapeutic vaccination. Previous studies have highlighted the importance of the virus-specific CD8+ T cell cytotoxic responses for the immune control of HIV and have oriented research on vaccine constructs based on CTL epitopes from circulating HIV-1 strains. The clinical trials with therapeutic vaccines to date have had limited success likely due to (i) a discrepancy between archived CTL epitopes in the viral reservoir and those in circulating viruses before antiretroviral therapy (ART) initiation and (ii) the lack of strong affinity between the selected CTL epitopes and the HLA grooves for presentation to CD8+ cells. To overcome these limitations, we launched the Provir/Latitude 45 study to identify conserved CTL epitopes in archived HIV-1 DNA according to the HLA class I alleles of aviremic patients, most of whom are under ART. The near full-length genomes or Gag, Pol and Nef regions of proviral DNA were sequenced by Sanger and/or Next Generation Sequencing (NGS). The HLA-A and B alleles were defined by NGS or molecular analysis. The TuTuGenetics software, which moves a sliding window of 8 to 10 amino acids through the amino acid alignment, was combined with the Immune Epitope Data Base (IEDB) to automatically calculate the theoretical binding affinity of identified epitopes to the HLA alleles for each individual. We identified 15 conserved epitopes in Pol (11), Gag (3), and Nef (1) according to their potential presentation by the dominant HLA-A and B alleles and now propose to use the corresponding conserved peptides in a multi-epitopic vaccine (HLA-fitted VAC, HFVAC). [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
10. Custom multi-tumor next-generation sequencing panel for routine molecular diagnosis of solid tumors: Validation and results from three-year clinical use.
- Author
-
Chevrier, Sandy, Brasselet, Astrid, Carnet, Marion, Chevriaux, Angélique, Gibeaud, Anne, Jourdain, Marine, Mananet, Hugo, Truntzer, Caroline, Beltjens, Françoise, Charon-Barra, Céline, Arnould, Laurent, Albuisson, Juliette, Comte, Anthony, Derangère, Valentin, Goussot, Vincent, and Boidot, Romain
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.